Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0000950170-25-086548
Filing Date
2025-06-16
Accepted
2025-06-16 08:15:41
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-1 apvo-2025-s1_-_june_offe.htm S-1 1191655
2 EX-4.20 apvo-ex4_20.htm EX-4.20 172350
3 EX-4.21 apvo-ex4_21.htm EX-4.21 200645
4 EX-5.1 apvo-ex5_1.htm EX-5.1 40179
5 EX-10.59 apvo-ex10_59.htm EX-10.59 334380
6 EX-10.60 apvo-ex10_60.htm EX-10.60 221765
7 EX-23.1 apvo-ex23_1.htm EX-23.1 4598
8 EX-FILING FEES apvo-exfiling_fees.htm EX-FILING FEES 104220
9 GRAPHIC img57496738_0.jpg GRAPHIC 12962
10 GRAPHIC img257065127_0.jpg GRAPHIC 6733
11 GRAPHIC img257065127_1.jpg GRAPHIC 74316
12 GRAPHIC img257065127_2.jpg GRAPHIC 250435
13 GRAPHIC img257065127_3.jpg GRAPHIC 14823
  Complete submission text file 0000950170-25-086548.txt   2765429
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-288061 | Film No.: 251048578
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)